Key Industry Figures to Present at First Ever Investment and Management Conference for Bioelectronic Medicine

NEW YORK, March 06, 2018 -- Neurotech Reports, the publisher of Neurotech Business Report newsletter, announced that several pioneers in the bioelectronic medicine industry will present at the 2018 Bioelectronic Medicine Forum, the first investment and management conference for this new industry. The inaugural event will take place on March 22, 2018 at the Millennium Broadway Times Square in New York, NY.

SetPoint Medical’s bioelectronic medicine therapy uses vagus nerve stimulation to take advantage of the inflammatory reflex. CVRx’ Barostim NEO device electrically activates the baroreceptors to treat hypertension. Gene Civillico, Ph.D., who heads up the National Institutes of Health’s SPARC program, will be a featured speaker at the 2018 Bioelectronic Medicine Forum. Eric Van Gieson, Ph.D., who heads up DARPA’s ElectRx program progeam, will be a featured speaker at the 2018 Bioelectronic Medicine Forum. Bioelectronic Medicine Forum logo

Featured speakers include Kris Famm, Ph.D., President of Galvani Bioelectronics, and Gene Civillico, Ph.D., the Program Manager for the National Institutes of Health’s SPARC program. Also presenting is Eric Van Gieson, Ph.D., Program Manager at DARPA's Biological Technologies Office, which oversees the ElectRx program. These two U.S. government programs have funded much of the early research into bioelectronic medicine.

Sessions will cover a range of technologies and indications for bioelectronic medicine, including applications in cardiovascular medicine, inflammation, gastrointestinal disorders, and many other clinical specialties. Attendees will hear from some of the leading researchers and entrepreneurs developing clinically and commercially promising products such as implanted vagus nerve stimulation systems to treat hypertension, and surface stimulation devices to treat a range of disorders.

Several early-stage and emerging bioelectronic medicine firms will be presenting at the conference. These include NeuSpera Medical, which is developing a unique mid-field power technology that uses the body as a waveguide to power bioelectronic devices. Also presenting is PathMaker Neurosystems, a manufacturer of noninvasive devices to treat neuromotor disorders, GiMer Medical, a Taiwanese manufacturer of pain stimulation devices, and CVRx, a manufacturer of implanted stimulation devices to treat heart failure and hypertension.

The conference is co-sponsored by the Feinstein Institute for Medical Research. Imran Eba of Action Potential Venture Capital, GSK’s venture arm in bioelectronic medicine, will serve as a moderator. The event takes place in the same venue and one day prior to the Future Leaders Conference, which is produced and organized by BioCentury, a global leader in business intelligence for the biopharma industry. BioCentury is pleased to serve as a marketing partner of the Bioelectronic Medicine Forum.

"Bioelectronic medicine represents one of the fastest growing segments of the life sciences industry. Participants at the 2018 Bioelectronic Medicine Forum will have an opportunity to help shape the future of this exciting field," said James Cavuoto, editor and Publisher of Neurotech Business Report.

For more information, contact James Cavuoto at 415-546-1259 or visit http://www.neurotechreports.com/pages/bioelectronic-medicine-forum.html.

MEDIA ONLY CONTACT:
James Cavuoto
Neurotech Reports
+1-415-546-1259
editorial[at]neurotechreports.com

Photos accompanying this announcement are available at

http://www.globenewswire.com/NewsRoom/AttachmentNg/18cf5a4c-08dc-4546-8622-4250ca3368f7

http://www.globenewswire.com/NewsRoom/AttachmentNg/56764bdc-7987-48af-a411-8dd292828837

http://www.globenewswire.com/NewsRoom/AttachmentNg/1c13045f-c65a-41e7-a652-a5091d5c945f

http://www.globenewswire.com/NewsRoom/AttachmentNg/caddf461-984c-41ee-afb7-7aea950631cd

http://www.globenewswire.com/NewsRoom/AttachmentNg/5a8689d8-8400-43f0-b4ea-add8efb87dcd